Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Boschetto, A. Fucili, D. Beltrame, A. Potena, L. Ballerin, C. E. Mapp, L. M Fabbri, E. De Rosa, C. Ceconi, R. Ferrari (Ferrara, Modena, Italy). Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications. Eur Respir J 2009; 34: Suppl. 53, 4466

Member's Comments

No comment yet.

Related content which might interest you: Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2011; 39: 51-58 Year: 2012 Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2012; 39: 51-58 Year: 2012 The prospective impact of chronic obstructive pulmonary disease on short-term prognosis of patients with chronic heart failure Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure Source: International Congress 2019 – More and more COPD Year: 2019 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Short-term outcomes in community heart failure patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Comorbidities and management in primary care Year: 2011 Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension Source: Annual Congress 2010 - COPD: management Year: 2010 Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Influence of concomitant chronic heart failure on incorrect evaluation of chronic obstructive pulmonary disease assessment tests Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Overall management of stable chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=258 Year: 2006 Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Socioeconomic burden of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=463 Year: 2006 Inflammatory biomarkers as outcome predictors of acute respiratory failure on top of chronic obstructive pulmonary diseases (COPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 The heart rate variability in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Chronic obstructive pulmonary disease: current burden and future projections Source: Eur Respir J 2006; 27: 397-412 Year: 2006